Association of single-nucleotide polymorphisms of CDH1 with nonsyndromic cleft lip with or without cleft palate in a northern Chinese Han population

Medicine (United States)

Volumn 96, Issue 5, 2017, Pages

  Song, Hongquan ^a   Wang, Xiaotong ^a   Yan, Jiaqun ^a   Mi, Na ^a   Jiao, Xiaohui ^a   Hao, Yanru ^b   Zhang, Wei ^a   Gao, Yuwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b PLASTIC SURGERY HOSPITAL   (China)

Author keywords

association; CDH1; NSCL P; polymorphism

Indexed keywords

UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC MODEL; GENETIC RISK; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MONSYNDROMIC CLEFT LIP; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUP; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 85013226646     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005574     Document Type: Article

References (26)

1. Mossey PA, Little J, Munger RG, et al. Cleft lip and palate. Lancet 2009;374:1773-85.
2. Dixon MJ, Marazita ML, Beaty TH, et al. Cleft lip and palate: Understanding genetic and environmental influences. Nat Rev Genet 2011;12:167-78.
3. Stanier P, Moore GE. Genetics of cleft lip and palate: Syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 2004;13(Spec No 1):R73-81.
4. Vogelaar IP, Figueiredo J, van Rooij IA, et al. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Hum Mol Genet 2013;22:919-26.
5. Hozyasz KK, Mostowska A, Wójcicki P, et al. Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate. Fam Cancer 2014;13:415-21.
6. Ittiwut R, Ittiwut C, Siriwan P, et al. Variants of the CDH1 (E-cadherin) gene associated with oral clefts in the Thai population. Genet Test Mol Biomarkers 2016;20:406-9.
7. Stemmler MP, Bedzhov I. A Cdh1HA knock-in allele rescues the Cdh1-/-phenotype but shows essential Cdh1 function during placentation. Dev Dyn 2010;239:2330-44.
8. Chen B, Zhou Y, Yang P, et al. CDH1-160CA polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 2011;55: 266-73.
9. Kerrigan JJ, Mansell JP, Sengupta A, et al. Palatogenesis and potential mechanisms for clefting. J R Coll Surg Edinb 2000;45:351-8.
10. Frebourg T, Oliveira C, Hochain P, et al. Cleft lip/palate and CDH1/Ecadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet 2006;43:138-42.
11. Montenegro MA, Rojas M, Dominguez S, et al. Cytokeratin, vimentin and E-cadherin immunodetection in the embryonic palate in two strains of mice with different susceptibility to glucocorticoid-induced clefting. J Craniofac Genet Dev Biol 2000;20:137-43.
12. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat 1995;154:8-20.
13. Katoh M. Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 2005;27:1677-83.
14. Tan EJ, Kahata K, Idås O, et al. The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition. Nucl Acids Res 2015;43:162-78.
15. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-8.
16. Bland JM, Altman DG. Multiple significance tests: The Bonferroni method. Br Med J 1995;310:1073-5.
17. Bureau A, Parker MM, Ruczinski I, et al. Whole exome sequencing of distant relatives in multiplex families implicates rare variants in candidate genes for oral clefts. Genetics 2014;197:1039-44.
18. Song Y, Zhang S. Association of CDH1 promoter polymorphism and the risk of non-syndromic orofacial clefts in a Chinese Han population. Arch Oral Biol 2011;56:68-72.
19. Rafighdoost H, Hashemi M, Narouei A, et al. Association between CDH1 and MSX1 gene polymorphisms and the risk of nonsyndromic cleft lip and/or cleft palate in a southeast Iranian population. Cleft Palate Craniofac J 2013;50:e98-104.
20. Krasone K, Lace B, Akota I, et al. IRF6 AP-2a binding site promoter polymorphism is associated with oral clefts in Latvia. Stomatologija 2014;16:132-6.
21. Letra A, Menezes R, Granjeiro JM, et al. AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts. Birth Defects Res A Clin Mol Teratol 2009;85:169-73.
22. Gurzu S, Sugimura H, Orlowska J, et al. New insights in histogenetic pathways of gastric cancer. Medicine (Baltimore) 2015;94:e1810.
23. Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol 2011;12:189-97.
24. Cattaneo F, Venesio T, Molatore S, et al. Functional analysis and casecontrol study of -160C/A polymorphism in the E-cadherin gene promoter: Association with cancer risk. Anticancer Res 2006;26: 4627-32.
25. Kluijt I, Siemerink EJ, Ausems MG, et al. CDH1-related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling. Int J Cancer 2012;131:367-76.
26. Benusiglio PR, Caron O, Consolino E, et al. Cleft lip, cleft palate, hereditary diffuse gastric cancer and germline mutations in CDH1. Int J Cancer 2013;132:2470.